Know Cancer

or
forgot password

Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study.


N/A
18 Years
N/A
Not Enrolling
Both
Cholangiocarcinoma

Thank you

Trial Information

Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study.


Inclusion Criteria:



- Hilar cholangiocarcinoma assessed by conventional imaging modalities (triphasic CT
scan of the liver) and thought to be potentially resectable.

Exclusion Criteria:

- Biliary drain inserted.

- Contraindication for MRI.

- Pregnant or breast-feeding.

- Uncontrolled diabetes (over 9.7 mmol/L).

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Principal Investigator

Ur Metser, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

U of Toronto, UHN

Authority:

Canada: Ethics Review Committee

Study ID:

07-0216

NCT ID:

NCT00604266

Start Date:

August 2007

Completion Date:

August 2008

Related Keywords:

  • Cholangiocarcinoma
  • Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.
  • Able to undergo PET/CT and MRI with Gadolinium
  • Cholangiocarcinoma
  • Klatskin's Tumor

Name

Location